Ryan Dunlap

Ryan Dunlap is a seasoned finance and operations executive who currently serves as a Board Member at CytoDyn Inc., a biopharmaceutical company.13 With over 25 years of experience in finance and operations leadership, Dunlap brings significant expertise to his role on the board.1

Professional Background

Current Position:: Ryan Dunlap is the Chief Financial Officer at Gurobi Optimization.25

Board Memberships::

• Director at CytoDyn Inc. (appointed on August 25, 2022)35
• Former Chairman of the Board of Directors at Oregon Bioscience Association (May 2016 - October 2019)4

Expertise and Experience

Dunlap has developed considerable expertise in several key areas:

• Strategy setting
• Improving operational efficiency and effectiveness
• Fundraising and investor relations
• Financial reporting and compliance
• Risk management

Previous Roles::

• CFO and COO for a growth equity-backed molecular diagnostics company
• CFO of a publicly traded biotechnology and pharmaceutical sales company
• Various financial and operational leadership roles in large, multinational organizations
• 11 years with public accounting firms such as PwC, KPMG, and Moss Adams

Achievements

• Helped more than double enterprise value over a 4-year period at a molecular diagnostics company
• Raised over $150 million to fund 300% growth at a biotech and pharmaceutical sales company
• Launched and supported investor reporting and SEC compliance functions

Education and Qualifications

• B.S. degree in Accounting from the University of Oregon
• Licensed and active CPA in the state of Oregon1

Ryan Dunlap's extensive experience in finance, operations, and the life sciences industry makes him a valuable asset to CytoDyn's Board of Directors.